VivoSim will offer liver and intestinal toxicology insights using its premier new approach methodologies (NAM) models, following the announcement of the FDA to phase out animal testing ...

AI-based computational models are expected to play a larger role in drug development. Animal testing requirements ... the National Toxicology Program and the Department of Veterans Affairs will ...

VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced today that its world-leading NAMkind™ platform for liver toxicology prediction, provided as a commercial service to pharma companies, was ...

Detailed price information for Vivosim Lab Inc (VIVS-Q) from The Globe and Mail including charting and trades.

VivoSim offers liver and intestinal toxicology insights using its premier new approach methodologies (NAM) models, following the announcement of FDA to phase out animal testing requirements in ...